Fibrinogen concentrate – a potential universal hemostatic agent

Bibliography

• Lak M, Keihani M, Elahi F, et al. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999;107(1):204-6
   PubMed Web of Science ®Google Scholar
• Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008;65(4):748-54
   PubMed Web of Science ®Google Scholar
• Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995;81(2):360-5
   PubMed Web of Science ®Google Scholar
• Martini WZ, Chinkes DL, Pusateri AE, et al. Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. Am J Physiol Endocrinol Metab 2005;289(5):E930-4
   PubMed Web of Science ®Google Scholar
• Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B. Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost 2009;7(7):1099-105
   PubMed Web of Science ®Google Scholar
• Fenger-Eriksen C, Anker-Moller E, Heslop J, et al. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005;94(3):324-9
   PubMed Web of Science ®Google Scholar
• Fries D, Krismer A, Klingler A, et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 2005;92(2):172-7
   Google Scholar
• Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007;105(4):905-17
   PubMed Web of Science ®Google Scholar
• Fries D, Innerhofer P, Reif C, et al. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesth Analg 2006;102(2):347-51
   PubMed Web of Science ®Google Scholar
• Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B. Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids. Acta Anaesthesiol Scand 2009;53(3):332-8
   PubMed Web of Science ®Google Scholar
• Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, et al. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008;101(6):769-73
   PubMed Web of Science ®Google Scholar
• Danes AF, Cuenca LG, Bueno SR, et al. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang 2008;94(3):221-6
   PubMed Web of Science ®Google Scholar
• Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 2008;18(3):151-7
   PubMed Web of Science ®Google Scholar
• Fenger-Eriksen C, Midtgaard JT, Kristensen BS, et al. Fibrinogen substitution improves whole blood clot firmness following dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy – a randomised placebo-controlled clinical trial. J Thromb Haemost 2009;7(5):795-802
   PubMed Web of Science ®Google Scholar
• Bolliger D, Szlam F, Molinaro RJ, et al. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009;102(6):793-9
   PubMed Web of Science ®Google Scholar
• Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995;6(8):743-6
   PubMed Web of Science ®Google Scholar
• FDA approves RiaSTAP for treatment of bleeding in patients with rare genetic defect. FDA News release. Washington, DC: FDA, 2009. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm109069.htm [Last accessed 31 July 2009]
   Google Scholar
• Available from: www.fda.gov/ bbs/topics/NEWS/ 2009/NEW01948.html
   Google Scholar
• Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005;3(8):1894-904
   PubMed Web of Science ®Google Scholar
• George JN. Platelets. Lancet 2000;355(9214):1531-9
   PubMed Web of Science ®Google Scholar
• Kreuz W, Meili E, Peter-Salonen K, et al. Pharmacokinetic properties of a pasteurised fibrinogen concentrate. Transfus Apher Sci 2005;32(3):239-46
   PubMed Web of Science ®Google Scholar
• Kreuz W, Meili E, Peter-Salonen K, et al. Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Transfus Apher Sci 2005;32(3):247-53
   PubMed Web of Science ®Google Scholar
• Martini WZ. Fibrinogen metabolic responses to trauma. Scand J Trauma Resusc Emerg Med 2009;17(1):2
   PubMed Web of Science ®Google Scholar
• Weisel JW. Fibrinogen and fibrin. Adv Protein Chem 2005;70:247-99
   PubMedGoogle Scholar
• Lowe GD, Rumley A, Mackie IJ. Plasma fibrinogen. Ann Clin Biochem 2004;41(Pt 6):430-40
   PubMed Web of Science ®Google Scholar
• Rumley A, Woodward M, Hoffmeister A, et al. Comparison of plasma fibrinogen by Clauss, prothrombin time-derived, and immunonephelometric assays in a general population: implications for risk stratification by thirds of fibrinogen. Blood Coagul Fibrinolysis 2003;14(2):197-201
   PubMed Web of Science ®Google Scholar
• Carroll RC, Craft RM, Chavez JJ, et al. Measurement of functional fibrinogen levels using the Thrombelastograph. J Clin Anesth 2008;20(3):186-90
   PubMed Web of Science ®Google Scholar
• Kalina U, Stohr HA, Bickhard H, et al. Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency. Blood Coagul Fibrinolysis 2008;19(8):777-83
   PubMed Web of Science ®Google Scholar
• Halbmayer WM, Haushofer A, Schon R, et al. Comparison of a new automated kinetically determined fibrinogen assay with the 3 most used fibrinogen assays (functional, derived and nephelometric) in Austrian laboratories in several clinical populations and healthy controls. Haemostasis 1995;25(3):114-23
   PubMedGoogle Scholar
• Innerhofer P, Fries D, Margreiter J, et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002;95(4):858-65
   PubMed Web of Science ®Google Scholar
• Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007;5(2):266-73
   PubMed Web of Science ®Google Scholar
• Lang T, Johanning K, Metzler H, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009;108(3):751-8
   PubMed Web of Science ®Google Scholar
• Velik-Salchner C, Haas T, Innerhofer P, et al. The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 2007;5(5):1019-25
   PubMed Web of Science ®Google Scholar
• Dickneite G, Pragst I, Joch C, Bergman GE. Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagul Fibrinolysis 2009 (In Press)
   PubMedGoogle Scholar
• Karlsson M, Ternstrom L, Hyllner M, et al. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008;48(10):2152-8
   PubMed Web of Science ®Google Scholar
• Ucar HI, Tok M, Atalar E, et al. Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery. Heart Surg Forum 2007;10(2):E131-5
   PubMed Web of Science ®Google Scholar
• Blome M, Isgro F, Kiessling AH, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005;93(6):1101-7
   PubMed Web of Science ®Google Scholar
• Österreichische gesellschaft für anaesthesiologie, reanimation und intensivemedizin, 2009. Availble from: www. oegari.at [Last accessed 25 July 2009]
   Google Scholar
• Rahe-Meyer N, Pichlmaier M, Haverich A, et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009;102(6):785-92
   PubMed Web of Science ®Google Scholar
• Elodi S, Varadi K. Optimization of conditions for the catalytic effect of the factor IXa-factor VIII complex: probable role of the complex in the amplification of blood coagulation. Thromb Res 1979;15(5-6):617-29
   PubMed Web of Science ®Google Scholar
• Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003;89(4):601-9
   PubMed Web of Science ®Google Scholar
• Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116(22):2544-52
   PubMed Web of Science ®Google Scholar
• Aronson D, Dann EJ, Bonstein L, et al. Impact of red blood cell transfusion on clinical outcomes in patients with acute myocardial infarction. Am J Cardiol 2008;102(2):115-9
   PubMed Web of Science ®Google Scholar
• Tanaka KA, Taketomi T, Szlam F, et al. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesth Analg 2008;106(3):732-8
   PubMed Web of Science ®Google Scholar
• Haas T, Fries D, Velik-Salchner C, et al. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg 2008;106(5):1360-5
   PubMed Web of Science ®Google Scholar
• De Lorenzo C, Calatzis A, Welsch U, Heindl B. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 2006;102(4):1194-200
   PubMed Web of Science ®Google Scholar
• Fries D, Haas T, Klingler A, et al. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy–a porcine model. Br J Anaesth 2006;97(4):460-7
   PubMed Web of Science ®Google Scholar
• Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008;64(2 Suppl):S79-85; discussion S85
   PubMed Web of Science ®Google Scholar
• Haas T, Fries D, Velik-Salchner C, et al. Fibrinogen in craniosynostosis surgery. Anesth Analg 2008;106(3):725-31
   PubMed Web of Science ®Google Scholar
• Heindl B, Delorenzo C, Spannagl M. High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion. Anaesthesist 2005;54(8):787-90
   PubMed Web of Science ®Google Scholar
• Karlsson M, Ternström L, Hyllner M, et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009;102(1):137-44
   PubMed Web of Science ®Google Scholar